TY - JOUR
T1 - The N-myc paradox
T2 - N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis
AU - van Noesel, Max M
AU - Pieters, Rob
AU - Voûte, P A
AU - Versteeg, Rogier
PY - 2003/7/18
Y1 - 2003/7/18
N2 - Neuroblastomas are characterized by defects in tumor necrosis factor-related apoptosis inducing ligand (TRAIL) induced apoptosis, especially down-regulation and methylation of Caspase-8 (CASP8). This defect is associated with amplification of N-myc. However, N-myc has also been implicated in induction of apoptosis, especially activation of CASP9 mediated apoptosis. Here we found that ectopic N-myc expression induces TRAIL susceptibility, both by CASP8 and CASP9 mediated apoptosis. N-myc did not modify CASP8 expression and methylation. CASP8 defects therefore represent an independent event in neuroblastoma, counteracting the N-myc induced susceptibility to apoptosis. Analysis of the CASP9 mediated route in a series of neuroblastoma cell lines, we found normal expression and no aberrant methylation of four apoptotic intermediates, including CASP9 itself.
AB - Neuroblastomas are characterized by defects in tumor necrosis factor-related apoptosis inducing ligand (TRAIL) induced apoptosis, especially down-regulation and methylation of Caspase-8 (CASP8). This defect is associated with amplification of N-myc. However, N-myc has also been implicated in induction of apoptosis, especially activation of CASP9 mediated apoptosis. Here we found that ectopic N-myc expression induces TRAIL susceptibility, both by CASP8 and CASP9 mediated apoptosis. N-myc did not modify CASP8 expression and methylation. CASP8 defects therefore represent an independent event in neuroblastoma, counteracting the N-myc induced susceptibility to apoptosis. Analysis of the CASP9 mediated route in a series of neuroblastoma cell lines, we found normal expression and no aberrant methylation of four apoptotic intermediates, including CASP9 itself.
KW - Apoptosis/drug effects
KW - Apoptosis Regulatory Proteins
KW - Caspase 8
KW - Caspase 9
KW - Caspases/genetics
KW - DNA Methylation
KW - DNA Primers/chemistry
KW - Enzyme Inhibitors/pharmacology
KW - Gene Amplification
KW - Genes, myc/physiology
KW - Humans
KW - Membrane Glycoproteins/pharmacology
KW - Neuroblastoma/metabolism
KW - Proto-Oncogene Proteins c-myc/metabolism
KW - RNA, Messenger/metabolism
KW - Receptors, Tumor Necrosis Factor/metabolism
KW - Reverse Transcriptase Polymerase Chain Reaction
KW - TNF-Related Apoptosis-Inducing Ligand
KW - Tumor Cells, Cultured
KW - Tumor Necrosis Factor-alpha/pharmacology
KW - Up-Regulation
U2 - 10.1016/s0304-3835(03)00101-0
DO - 10.1016/s0304-3835(03)00101-0
M3 - Article
C2 - 12880977
SN - 0304-3835
VL - 197
SP - 165
EP - 172
JO - Cancer letters
JF - Cancer letters
IS - 1-2
ER -